BA
IMGN

BlackRock Advisors’s Immunogen Inc IMGN Stock Holding History

BlackRock Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$206K Buy
101,201
+2,444
+2% +$4.91K ﹤0.01% 2707
2016
Q3 		$265K Sell
98,757
-1,267
-1% -$3.68K ﹤0.01% 2532
2016
Q2 		$308K Buy
100,024
+31,295
+46% +$196K ﹤0.01% 2381
2016
Q1 		$586K Buy
68,729
+2,800
+4% +$23.7K ﹤0.01% 1995
2015
Q4 		$895K Sell
65,929
-30,613
-32% -$377K ﹤0.01% 1768
2015
Q3 		$927K Sell
96,542
-1,841
-2% -$26.9K ﹤0.01% 1744
2015
Q2 		$1.42M Buy
98,383
+43,016
+78% +$472K ﹤0.01% 1433
2015
Q1 		$496K Buy
55,367
+8,055
+17% +$58.3K ﹤0.01% 2077
2014
Q4 		$289K Sell
47,312
-2,248
-5% -$20.6K ﹤0.01% 2377
2014
Q3 		$525K Sell
49,560
-1,622
-3% -$18.3K ﹤0.01% 1931
2014
Q2 		$607K Sell
51,182
-19,959
-28% -$251K ﹤0.01% 1873
2014
Q1 		$1.06M Buy
71,141
+16,062
+29% +$253K ﹤0.01% 1488
2013
Q4 		$808K Buy
55,079
+3,960
+8% +$60.9K ﹤0.01% 1660
2013
Q3 		$870K Buy
51,119
+38
+0.1% +$668 ﹤0.01% 1505
2013
Q2 		$847K Buy
+51,081
New +$828K ﹤0.01% 1458

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock Advisors's IMGN Position: Q4 2016 in Review

BlackRock Advisors increased its Immunogen Inc (IMGN) stake by 2.5% in Q4 2016, buying an estimated $4.91K and bringing the position to 101,201 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #2707.

BlackRock Advisors first reported a position in IMGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.42M in Q2 2015. 156 funds tracked by Wall St. Rank hold IMGN as of Q4 2016.

  • BlackRock Advisors held 101,201 shares of Immunogen Inc worth $206K as of Q4 2016.
  • BlackRock Advisors bought 2,444 Immunogen Inc shares in Q4 2016, an estimated $4.91K.
  • Immunogen Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2707 holding.
  • BlackRock Advisors first reported a position in Immunogen Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Immunogen Inc position peaked at $1.42M in Q2 2015.
  • 156 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.